Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Let's get started. Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior Biotech analysts here at JPMorgan. I am joined by Priyanka Grover, [Malcom Kuno] and (inaudible) Smith from the team. Our next presenting company is Neurocrine, and presenting on behalf of the company, we have CEO, Kevin Gorman.
I want to remind all the attendees of this session that there is an ask a question feature in the portal and I would be happy to ask a question on your behalf, if you put a question in the portal. And with that, Kevin, take it away.
Thank you very much, Anupam, and thank you also, JPMorgan for the ability to present here today. I was really looking forward to meeting everyone in person, but we're back in this virtual world. I hope to be able through this presentation has been preparing for it to be able to generate and show you the excitement that we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |